Original InvestigationLong-Term Follow-Up of Complete Versus Lesion-Only Revascularization in STEMI and Multivessel Disease: The CvLPRIT Trial
Under an Elsevier user license
open archive
Central Illustration
Key Words
complete revascularization
multivessel disease
myocardial infarction
noninfarct-related lesion
primary percutaneous coronary intervention
ST-elevation
Abbreviations and Acronyms
CR
complete revascularization
FFR
fractional flow reserve
IDR
ischemia-driven revascularization
IRA
infarct-related artery
MACE
major adverse cardiovascular event
N-IRA
noninfarct-related artery
PCI
percutaneous coronary intervention
P-PCI
primary percutaneous coronary intervention
STEMI
ST-segment elevation myocardial infarction
TLF
target lesion failure
TVR
target-vessel revascularization
Cited by (0)
The CvLPRIT trial was funded by the British Heart Foundation (SP/10/001) with support from the National Institute for Health Research (NIHR) Comprehensive Local Research Networks, in particular, by the NIHR infrastructure at Leicester Leeds. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
© 2019 by the American College of Cardiology Foundation. Published by Elsevier.